ING Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $937K | Buy |
13,412
+8,372
| +166% | +$585K | 0.01% | 406 |
|
|
2025
Q1 | $370K | Buy |
+5,040
| New | +$370K | ﹤0.01% | 455 |
|
|
2023
Q4 | – | Sell |
-70,774
| Closed | -$4.79M | – | 553 |
|
|
2023
Q3 | $4.79M | Buy |
70,774
+67,231
| +1,898% | +$4.55M | 0.04% | 278 |
|
|
2023
Q2 | $254K | Sell |
3,543
-857
| -19% | -$61.3K | ﹤0.01% | 474 |
|
|
2023
Q1 | $305K | Sell |
4,400
-50,801
| -92% | -$3.53M | ﹤0.01% | 497 |
|
|
2022
Q4 | $3.74M | Buy |
55,201
+9,438
| +21% | +$640K | 0.04% | 272 |
|
|
2022
Q3 | $2.51M | Buy |
45,763
+12,053
| +36% | +$661K | 0.04% | 251 |
|
|
2022
Q2 | $2.23M | Buy |
33,710
+18,823
| +126% | +$1.24M | 0.03% | 380 |
|
|
2022
Q1 | $988K | Buy |
+14,887
| New | +$988K | 0.01% | 459 |
|
|
2014
Q2 | – | Sell |
-20,000
| Closed | -$649K | – | 643 |
|
|
2014
Q1 | $649K | Buy |
+20,000
| New | +$649K | ﹤0.01% | 601 |
|
|
2013
Q4 | – | Sell |
-311,484
| Closed | -$8.09M | – | 690 |
|
|
2013
Q3 | $8.09M | Sell |
311,484
-1,490,358
| -83% | -$38.7M | 0.04% | 327 |
|
|
2013
Q2 | $42.6M | Buy |
+1,801,842
| New | +$42.6M | 0.23% | 117 |
|